Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Provisional Angioplasty in Left Main: What MSA Values Should We Target?

Percutaneous coronary intervention (PCI) of the unprotected left main coronary artery (LMCA) represents one of the most challenging scenarios. Clinical practice guidelines recommend the use of IVUS as an essential tool to optimize outcomes, with clear advantages over conventional angiography in selecting device size, detecting malapposition, and particularly in identifying underexpansion.

Nevertheless, uncertainty remains regarding the optimal threshold or “target value” of minimal stent area (MSA) in the LMCA, especially in the provisional crossover strategy with a single stent toward the left anterior descending artery (LAD). 

The Asan Medical Center group (Seoul), led by Kim et al., had previously evaluated these “cut-off points” using the 5-6-7-8 criteria and other MSA values in two-stent PCI for LMCA. In this new investigation, presented in EuroIntervention, they propose quantitative MSA thresholds to predict five-year events in single-stent procedures.

The study included 829 patients with unprotected LMCA treated with DES through a LMCA-LAD crossover strategy optimized with IVUS. Cases requiring a second stent in the circumflex (Cx) ostium, crossover to Cx, prior CABG, or in-stent restenosis of the LMCA were excluded. The mean post-PCI MSA was 11.9±2.5 mm² in the proximal LMCA, 10.1±2.2 mm² in the distal LMCA, and 8.7±1.9 mm² in the LAD ostium.

Read also: Predilatation in Self-Expanding Valves.

When assessing optimal thresholds by ROC curves to predict MACE, adequate values were determined as proximal LMCA ≥11.4 mm² (AUC 0.62), distal LMCA ≥8.4 mm² (AUC 0.58), and LAD ostium ≥8.1 mm² (AUC 0.57). Using these cut-offs, underexpansion rates were 46.2%, 19.2%, and 41.1%, respectively. 

Subexpansion <11.4 mm² in the proximal LMCA doubled the risk of five-year MACE (adjusted HR 2.34; p<0.001) and was associated with increased all-cause mortality (adjusted HR 2.12; p=0.003). In adjusted models including all three MSA values, only proximal LMCA MSA retained independent association with MACE.

Read also: Tricuspid Regurgitation, TriBicaval Registry.

Additionally, double distal underexpansion (distal LMCA and LAD ostium) proved hazardous, showing higher MACE risk (24.2%) and an independent association with increased TLR (adjusted HR 4.30).

Conclusions

This study, focused on the provisional single-stent technique, highlights the importance of IVUS and the relationship between underexpansion and adverse outcomes across LMCA segments. A proximal LMCA MSA ≥11.4 mm² was the only parameter with independent prognostic value after multivariable adjustment, underscoring the need for vigorous post-dilatation with larger diameter balloons at high pressure until the proposed threshold is achieved. Moreover, the presence of double distal underexpansion significantly increases the risk of MACE and TLR.

Original Title: Optimal minimal stent area after crossover stenting in patients with unprotected left main coronary artery disease.

Reference: Kim JH, Kang DY, Ahn JM, Kweon J, Chae J, Wee SB, An SY, Park H, Kang SJ, Park DW, Park SJ. Optimal minimal stent area after crossover stenting in patients with unprotected left main coronary artery disease. EuroIntervention. 2025 Sep 15;00(0):000-000. doi: 10.4244/EIJ-D-25-00122.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Omar Tupayachi
Dr. Omar Tupayachi
Member of the Editorial Board of solaci.org

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...